Golden Cross event and heavy insider buying on GALT Long
Galectin Therapeutics Inc.NASDAQ
Description
⋅
- Golden Cross formed
- CEO takes 80% pay in stock
- Billonaire chairman provided financing
- Developing the leading drug candidate for advanced liver disease